midkine mRNA program (Roquefort Therapeutics)

N/A

Report date: 2025/03/20 15:23:43
NME

Base Information

Drug Namemidkine mRNA program (Roquefort Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > LipidSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionMidkine modulators
TargetsMidkine
Therapy Area/IndicationsLiver NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRoquefort Therapeutics plc
China Registration ClassN/A

Develop Information

Active CompaniesRoquefort Therapeutics plc
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A